Analysis of protein denaturation, aggregation and post-translational modification by agarose native gel electrophoresis.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Mar 2021
Historique:
received: 26 11 2020
revised: 09 01 2021
accepted: 12 01 2021
pubmed: 18 1 2021
medline: 30 4 2021
entrez: 17 1 2021
Statut: ppublish

Résumé

Agarose native gel electrophoresis has been developed to separate proteins and protein complexes in the native state. Here, we applied this technology to analyze proteins that undergo degradation, post-translational modification or chemical/physical changes. Antibodies showed aggregation/association upon acid or heat treatment. Limited reduction of disulfide bonds resulted in non-covalent aggregation of bovine serum albumin and cleavage of only inter-chain linkages of an antibody that had no effects on its overall structure. Native agarose gel analysis showed changes in mobility of human transferrin upon Fe

Identifiants

pubmed: 33454336
pii: S0141-8130(21)00105-7
doi: 10.1016/j.ijbiomac.2021.01.075
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0
Protein Aggregates 0
Transferrin 0
Viral Proteins 0
hemoglobin A1c protein, human 0
Serum Albumin, Bovine 27432CM55Q
Sodium Dodecyl Sulfate 368GB5141J
Hydrogen Peroxide BBX060AN9V
ZAP-70 Protein-Tyrosine Kinase EC 2.7.10.2
ZAP70 protein, human EC 2.7.10.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

589-596

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Chiaki Sakuma (C)

Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan.

Yui Tomioka (Y)

Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan.

Cynthia Li (C)

HTL Biosolutions, Inc., 4010 Adoflo Road, Ste. B, Camrillo, CA 93012, USA.

Takashi Shibata (T)

Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan.

Masataka Nakagawa (M)

Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan.

Yasunori Kurosawa (Y)

Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan; Abwiz Bio Inc., 9823 Pacific Heights Blvd, San Diego, CA 92121, USA.

Tsutomu Arakawa (T)

Alliance Protein Laboratories, 13380 Pantera Rd, San Diego, CA 92130, USA. Electronic address: tarakawa2@aol.com.

Teruo Akuta (T)

Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan. Electronic address: t.akuta@kyokutoseiyaku.co.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH